<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2207200118
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Metolina 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        METOPROLOL TARTRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        Store below 30°C ,  protect from Light
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        23.199
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Aurobindo Pharma Limited " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Limited 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 3103]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Saudi Arabia Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Saudi Arabia Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Metolina contains metoprolol tartrate, which belongs to a group of medicines called beta-blockers. Metoprolol tartrate reduces the effect of the stress hormones on the heart in connection with physical and mental exertion. This results in the heart beating slower (pulse rate is reduced).</p><p><strong>It is used to treat:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; high blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp; angina pectoris (pain in the chest caused by lack of oxygen in the heart)</p><p>&middot;&nbsp;&nbsp;&nbsp; irregular heart rhythm (arrhythmia).</p><p>in adults.</p><p><strong>It is used to prevent:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; migraine</p><p>&middot;&nbsp;&nbsp;&nbsp; heart damage, heart death or further heart attacks after a heart attack.</p><p>&nbsp;in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take METOLINA</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to metoprolol tartrate or any of the other ingredients of this medicine (listed in section 6) or to other similar medicines (beta-blockers)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have heart conduction problems (serious <em>AV-block or sinoatrial block</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from sick sinus syndrome</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have untreated heart failure, have untreated heart failure, are receiving treatment to increase heart contractions or are in shock caused by heart problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from severely blocked blood vessels, including blood circulation problems (which may cause your fingers and toes to tingle or turn pale or blue)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have a slow heart rate (less than 50 beats/min)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have very low blood pressure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from increased acidity of the blood (metabolic acidosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have severe asthma or COPD (chronic obstructive pulmonary disease)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; are receiving other blood pressure lowering medicines such as verapamil and diltiazam by intravenous injection. See also &ldquo;Other medicines and Metoprolol tartrate&rdquo;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; are using antiarrrhythmics such as disopyramide. See also &ldquo;Other medicines and Metoprolol tartrate&rdquo;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have untreated high blood pressure due to tumour of the adrenal medulla (phaechromocytoma).</p><p><strong>&nbsp;</strong></p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking METOLINA if you have any of the following conditions:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; asthma</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have diabetes mellitus (low blood sugar levels may be hidden by this medicine)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have high blood pressure due to tumour of the adrenal medulla (treated phaeochromocytoma)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; are having treatment to reduce allergic reactions. Metoprolol tartrate may increase your hypersensitivity to the substances you are allergic to and increase the severity of allergic reactions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have an overactive thyroid, (symptoms such as increased heart rate, sweating, tremor, anxiety, increased appetite or weight loss may be hidden by this medicine)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have or have suffered from skin rashes called psoriasis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from blood circulation problems (in the fingers, toes, arms and legs)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from a heart conduction disorder (AV block)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have a type of chest pain called Prinzmetal&rsquo;s angina.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have heart failure and one of the following:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; had a heart attack or angina attack in the last 28 days</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced kidney or liver function</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; are under 40 years old or over 80 years old</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diseases of the heart valves</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; enlarged heart muscle</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; had heart surgery in the last 4 months</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have unstable heart failure.</p><p>If are going to have an anaesthetic, please tell your doctor or dentist that you are taking Metoprolol tartrate.</p><p><em>Children and adolescents</em></p><p>There is limited data on the use of metoprolol in children and adolescents, therefore the use of metoprolol is not recommended.</p><p>&nbsp;</p><p><strong>Other medicines and METOLINA </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Metoprolol tartrate tablets can affect how some other medicines work, and some medicines an also affect how metoprolol work. If Metoprolol tartrate tablets are to be combined with the medicines listed below, you must consult your doctor before taking this medicine:</p><p><u>The following combination with metoprolol should be avoided:</u></p><p>&middot;&nbsp;&nbsp;&nbsp; Barbituric acid derivatives e.g. phenobarbital (used to treat epilepsy)</p><p>&middot;&nbsp;&nbsp;&nbsp; Propafenone, quinidine, verapamil, diltiazem, nifedipine and amlodipine (used to treat cardiovascular disease)</p><p><u>The following combinations with metoprolol may require dose adjustment:</u></p><p>&middot;&nbsp;&nbsp;&nbsp; Amiodarone, disopyramide (for irregular heart rhythm)</p><p>&middot;&nbsp;&nbsp;&nbsp; Indomethacin, sulindac, diclofenac and foctafenine (medicines used to reduce inflammation, fever and pain)</p><p>&middot;&nbsp;&nbsp;&nbsp; Fluoxetine, paroxetine and bupropion (medicines used to treat depression)</p><p>&middot;&nbsp;&nbsp;&nbsp; Thioridazine (antipsychotic)</p><p>&middot;&nbsp;&nbsp;&nbsp; Ritonavir (antiretroviral)</p><p>&middot;&nbsp;&nbsp;&nbsp; Diphenhydramine (antihistamine)</p><p>&middot;&nbsp;&nbsp;&nbsp; Hydroxychloroquine, mefloquine (used in malaria)</p><p>&middot;&nbsp;&nbsp;&nbsp; Terbinafine (for fungal infection of skin)</p><p>&middot;&nbsp;&nbsp;&nbsp; Cimetidine (for ulcers)</p><p>&middot;&nbsp;&nbsp;&nbsp; Digitalis glycosides such as digoxin (used in heart failure)</p><p>&middot;&nbsp;&nbsp;&nbsp; Epinephrine (medicine used in acute shock and severe allergic reaction)</p><p>&middot;&nbsp;&nbsp;&nbsp; Phenylpropanolamine (used to reduce swelling of the nasal mucosa)</p><p>&middot;&nbsp;&nbsp;&nbsp; Other beta blockers e.g. eye drops</p><p>&middot;&nbsp;&nbsp;&nbsp; Monoamine oxidase inhibitors (MAOIs) (used to treat depression and Parkinson&rsquo;s disease)</p><p>&middot;&nbsp;&nbsp;&nbsp; Clonidine, guanfacin, moxonidine, methyldopa, rilmenidine (blood pressure lowering medicines)</p><p>&middot;&nbsp;&nbsp;&nbsp; Ergotamine (used in migraine)</p><p>&middot;&nbsp;&nbsp;&nbsp; Nitrates such as nitroglycerine (used in angina)</p><p>&middot;&nbsp;&nbsp;&nbsp; General anaesthetics</p><p>&middot;&nbsp;&nbsp;&nbsp; Insulin and oral antidiabetic (for reducing blood sugar level) medicines</p><p>&middot;&nbsp;&nbsp;&nbsp; Prazosine, tamsulosin, terazosine, doxazosine (alpha blockers, used to treat high blood pressure and benign prostatic hyperplasia)</p><p>&middot;&nbsp;&nbsp;&nbsp; Lidocaine (local anaesthetic)</p><p>&middot;&nbsp;&nbsp;&nbsp; Rifampicine (used to treat tuberculosis)</p><p>&middot;&nbsp;&nbsp;&nbsp; Antacids (used for stomach upsets).</p><p><strong>Metoprolol tartrate with alcohol</strong></p><p>You are advised to avoid alcohol whilst taking this medicine. Alcohol may increase the blood pressure lowering effect of Metoprolol tartrate.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>Metoprolol tartrate is not recommended during pregnancy or breastfeeding. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Driving and using machines</strong></p><p>Metoprolol tartrate may make you feel tired and dizzy. Make sure you are not affected before you drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>&nbsp;</strong></p><p>Metoprolol tartrate should be taken without food and on an empty stomach.</p><p>Metoprolol tartrate tablets can be divided into equal doses.</p><p><strong>The recommended dose is:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>High blood pressure:</strong> Initially 100 mg daily.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Angina pectoris:</strong> Usually 50-100 mg twice daily.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Irregular heart beats (arrhythmia): </strong>100-200 mg daily.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Preventive therapy after a heart attack: </strong>The usual maintenance dose is 100 mg twice daily.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Prevention of migraine:</strong> 50 &ndash; 100 mg twice dialy.</p><p><strong>&nbsp;</strong></p><p><strong>If you take more METOLINA than you should</strong></p><p>If you have accidentally taken more than the prescribed dose, contact your nearest casualty</p><p>department or tell your doctor or pharmacist at once. Depending on the extent of the overdose, this can lead to excessive reduction in blood pressure and a decrease in heart rate. As a consequence of the failure of heart function, this can even lead to cardiac arrest, heart muscle weakness and shock. Other symptoms include problems in breathing, constriction of the muscles in the respiratory tract, vomiting, disturbances of consciousness and even occasionally generalised seizures.</p><p>&nbsp;</p><p><strong>If you forget to take METOLINA</strong></p><p>If you forget to take a dose, take it as soon as you remember, unless it is nearly time for your next dose. Then go on as before. Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop taking METOLINA</strong></p><p>Do not suddenly stop taking Metoprolol tartrate as this may cause worsening of heart failure and increase the risk of heart attack. Only change the dose or stop the treatment in consultation with your doctor.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Stop treatment and contact a doctor at once if you have:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>an allergic reaction </strong>such as itchy skin rash, flushing, swelling of the face, lips, tongue or throat, or difficulty breathing or swallowing.</p><p>This is a very serious but rare side effect.</p><p>You may need urgent medical attention or hospitalisation.</p><p><strong>Tell your doctor if you notice any of the following side effects or notice any other effects not listed:</strong></p><p><strong>Very common </strong>(may affect more than 1 in 10 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling faint on standing due to low blood pressure, tiredness.</p><p><strong>Common </strong>(may affect up to 1 in 10 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slow heart rate,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulties in maintaining balance (very rare with fainting),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold hands and feet,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; palpitation,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; constipation,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomach pain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath with strenuous physical activity.</p><p>&nbsp;</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weight gain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; depression</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; concentration problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inability to sleep (insomnia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; drowsinees</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nightmares</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tingling in the skin,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; temporary worsening of symptoms of heart failure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disturbances in the conduction of the heart</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; spasmodic contraction of the smooth muscle of the bronchi (causing shortness of breath),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rashes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased sweating</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fluid retention</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle cramps</p><p>&nbsp;</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; worsening of diabetes,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anxiety,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; visual disturbances,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry or irritated eyes,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; conjunctivitis,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; impotence, other sexual dysfunctions,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Peyronie&rsquo;s syndrome (bending of penis on erection),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irregular heart beat,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart conduction disturbances,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry mouth,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; runny nose,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hair loss,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in liver function tests.</p><p>&nbsp;</p><p><strong>Very rare</strong> (may affect up to 1 in 10,000 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in blood cells,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; forgetfulness, memory impairment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; confusion,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hallucinations,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; personality changes e.g. mood changes,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ringing in the ears (tinnitus),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hearing problems,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taste changes,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the liver (hepatitis),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sensitivity to light,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; worsening or new psoriasis, psoriasis like changes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle weakness,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; joint pain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tissue death in patients with severe circulation disturbances.</p><p>&nbsp;</p><p><strong><u>Reporting of side effects</u></strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the blister or carton after EXP. The expiry date refers to the last day of that month.</p><p>Store below 30&deg;C.</p><p>Protect from light.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The active substance</strong> is Metoprolol Tartrate.</p><p>Each film-coated tablet contains 50 mg or 100 mg of Metoprolol tartrate.</p><p><strong>- The other ingredients are:</strong></p><p><em>Tablet core:</em><strong> </strong>Cellulose microcrystalline, Maize starch, Sodium starch glycolate, Silica colloidal anhydrous, Sodium lauryl sulfate, Talc, Magnesium stearate.</p><p><em>Tablet coating:</em></p><p><strong>50 mg</strong>: Hypromellose, Titanium dioxide, Polysorbate 80, Talc, Iron oxide red.</p><p><strong>100 mg</strong>: Hypromellose, Titanium dioxide, Macrogol, Polysorbate 80, Talc, FD&amp;C Blue #2/Indigo carmine aluminium lake.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Film-coated tablet.  

METOLINA 50:  
Peach coloured, round shaped, film-coated tablets, debossed with ‘C over 74’ on one side and deep score line on the other side. 

METOLINA 100:  
Light blue coloured, round shaped, film-coated tablets, debossed with ‘C over 75’ on one side and deep score line on the other side. 

METOLINA Film-coated tablets are available in Clear PVC/PVDC - Aluminium foil blister pack.

METOLINA 50 mg & 100 mg Film-coated tablets are supplied in 30's pack (10's Blister x 3).


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer:</strong></p><p>AUROBINDO PHARMA LIMITED, UNIT &ndash; VII,</p><p>SEZ, TSIIC, Plot No.SI, Survey No&#39;s: 411/P, 425/P, 434/P, 435/P &amp; 458/P,</p><p>Green Industrial Park, Polepally Village, Jedcherla Mandal,</p><p>Mahaboobnagar District, Telangana State, India.</p><p><strong>&nbsp;</strong></p><p><strong>Marketing Authorization Holder:</strong></p><p>Aurobindo Pharma Saudi Arabia Limited,</p><p>Jeddha, Saudi Arabia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                07/2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي ميتولينا على ميتوبرولول تارترات، والذي ينتمي لمجموعة من الأدوية تُسمى كابحات بيتا. يُخفض ميتوبرولول تارترات من تأثير هرمونات التوتر على القلب بالتزامن مع المجهود الجسدي والعقلي، مما يؤدي إلى نبض القلب بصورة ابطأ (انخفاض معدل الخفقان).</p><p dir="RTL"><strong>يُستخدم لعلاج:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الذبحة الصدرية (ألم بالصدر ينتج عن نقص الأكسجين في القلب).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اضطراب نظم القلب (اضطراب النظم).</p><p dir="RTL">&nbsp;في البالغين.</p><p dir="RTL"><strong>يُستخدم لمنع:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الصداع النصفي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تلف القلب أو موت القلب أو حدوث نوبات قلبية إضافية بعد النوبة القلبية الحالية.</p><p dir="RTL">&nbsp;في البالغين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p dir="RTL"><strong>&nbsp;لا تأخذ ميتولينا</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه ميتوبرولول تارترات أو أي من المكونات الأخرى لهذا الدواء (المذكورة في القسم 6)، أو تجاه الأدوية المماثلة الأخرى (كابحات بيتا)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا <strong>بمشاكل بالتوصيل القلبي</strong> (<strong><em>تثبيط أذيني بطيني أو تثبيط جيبي أذيني</em></strong> حاد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بمتلازمة العقدة الجيبية المريضة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بفشل قلبي غير مُعالج، أو تتلقى علاجًا لزيادة انقباضات القلب أو تمر بصدمة ناتجة عن مشاكل قلبية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من انسداد حاد بالأوعية الدموية، بما في ذلك مشاكل الدورة الدموية (والتي قد تؤدي إلى ارتعاش أصابع يديك أو قدميك، أو تحولها للون الشاحب أو الأزرق)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان معدل نبض قلبك منخفض (أقل من 50 نبضة/دقيقة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان ضغط دمك شديد الانخفاض</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من زيادة بحموضة الدم (حموضة أيضية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ربو شديد أو مرض الانسداد الرئوي المزمن (COPD)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتلقى أدوية أخرى مُخفضة لضغط الدم عن طريق الحقن الوريدي، مثل فيراباميل وديلتيازيم. انظر أيضًا &quot;الأدوية الأخرى وميتوبرولول تارترات&quot;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تستعمل مضادات اضطراب النظم، مثل ديسوبيراميد. انظر أيضًا &quot;الأدوية الأخرى وميتوبرولول تارترات&quot;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بارتفاع غير مُعالج لضغط الدم نتيجة وجود أورام بالنخاع الكظري (ورم القواتم البنية).</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي قبل أخذ ميتولينا، إذا كنت تعاني من أي من الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الربو</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السكري (فقد يُخفي هذا الدواء علامات انخفاض مستويات السكر بالدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدم الناتج عن أورام النخاع الكظري (ورم القواتم البنية غير المُعالج)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتلقى علاجًا لخفض التفاعلات التحسسية؛ فقد يتسبب ميتوبرولول في زيادة الحساسية الشديدة تجاه المواد التي لديك حساسية تجاهها، وقد يؤدي إلى زيادة حدة التفاعلات التحسسية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط نشاط الغدة الدرقية (قد يتسبب هذا الدواء في إخفاء الأعراض المتمثلة في زيادة نبض القلب أو التعرق أو الارتعاش أو القلق أو زيادة الشهية أو فقدان الوزن)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أو عانيت قبل من طفح جلدي يُسمى الصدفية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل بالدورة الدموية (في أصابع اليدين والقدمين، واليدين والقدمين نفسهما)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب بالتوصيل القلبي (تثبيط أذيني بطيني)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوع من الألم الصدري يُسمى ذبحة برنزميتال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل قلبي يصاحبه واحد من التالي:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبة قلبية أو ذبحة صدرية خلال الأيام الثمانية والعشرين الأخيرة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض بوظائف الكلى أو الكبد</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن كان عمرك أقل من 40 عامًا أو أكثر من 80 عامًا</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمراض بالصمامات القلبية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضخم بعضلة القلب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن كنت أجريت جراحة بالقلب في الشهور الأربعة الأخيرة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل قلبي غير مستقر.</p><p dir="RTL">في حالة الحاجة إلى الخضوع للتخدير، من فضلك أعلم الطبيب المعالج أو طبيب الأسنان أنك تأخذ ميتوبرولول تارترات.</p><p dir="RTL"><em>الأطفال والمراهقون</em></p><p dir="RTL">هناك بيانات محدودة عن استعمال ميتوبرولول مع الأطفال والمراهقين، وبالتالي لا يوصى باستعمال ميتوبرولول مع تلك الفئة العمرية.</p><p>&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى وميتولينا</strong></p><p dir="RTL">&nbsp;اعلم طبيبك إن كنت تأخذ أو أخذت حديثًا أو قد تأخذ أي أدوية أخرى.</p><p dir="RTL">قد يؤثر ميتوبرولول تارترات على آلية عمل بعض الأدوية، وقد تؤثر بعض الأدوية على آلية عمل ميتوبرولول بالمثل. يجب أن تستشير طبيبك قبل أخذ هذا الدواء في حالة استعمال أقراص ميتوبرولول تارترات مع الأدوية المذكورة أدناه:</p><p dir="RTL"><u>يجب تجنب أخذ الأدوية التالية مع ميتوبرولول:</u></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مشتقات حامض الباربيتوريك، مثل فينوباربيتال (يُستخدم لعلاج الصرع)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; بروبافينون، كينيدين، فيراباميل، ديلتيازيم، نيفيديبين، أملوديبين (يُستخدم لعلاج الأمراض القلبية الوعائية)</p><p dir="RTL"><u>قد توجد حاجة لتعديل الجرعة عند أخذ الأدوية التالية مع ميتوبرولول:</u></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; أميودارون، ديسوبيراميد (لاضطراب نبض القلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إندوميثاسين، سولينداك، ديكلوفيناك، فوكتافينين (أدوية تُستخدم لخفض الالتهاب والحمى والألم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فلوكسيتين، باروكسيتين، بابروبيون (أدوية تُستخدم لعلاج الاكتئاب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ثيوريدازين (مضاد للذهان)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ريتونافير (مضاد للفيروسات الانعكاسية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; دايفينهيدرامين (مضاد للهيستامين)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; هيدروكسي كلوروكين، ميفلوكين (لعلاج الملاريا)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تيربينافين (لعلاج عدوات الجلد الفطرية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سيميتيدين (للقرح)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجليكوسيدات الديجيتالية مثل ديجوكسين (لعلاج فشل القلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إيبينيفرين (دواء يُستخدم في حالة الصدمات الحادة والتفاعلات التحسسية الشديدة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فينيل بروبانولامين (يُستخدم لخفض التورم بالأغشية المخاطية الأنفية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; كابحات بيتا الأخرى، مثل قطرات العين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مثبطات أوكسيداز أحادي الأمين (MAOIs) (تستخدم لعلاج الاكتئاب وداء باركنسون)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; كلونيدين، جوانفاسين، موكسونيدين، ميثيل دوبا، ريلمينيدين (أدوية مُخفضة لضغط الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إيرجوتامين (لعلاج الصداع النصفي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; النترات مثل النيتروجليسرين (لعلاج الذبحة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; أدوية التخدير العامة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الإنسولين ومضادات السكري الفموية (لخفض مستوى السكر بالدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; برازوسين، تامسولوسين، تيرازوسين، دوكسازوسين (كابحات ألفا، تُستخدم لعلاج ارتفاع ضغط الدم وتضخم البروستاتا الحميد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ليدوكين (مخدر موضعي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ريفامبيسين (لعلاج السل)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مضادات الحموضة (لتقلبات المعدة)</p><p dir="RTL"><strong>ميتوبرولول تارترات والكحول</strong></p><p dir="RTL">يُنصح بتجنب الكحول أثناء أخذ هذا الدواء، فقد يؤدي الكحول إلى زيادة تأثير ميتوبرولول تارترات المُخفض لضغط الدم.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">لا يُنصح باستعمال ميتوبرولول تارترات أثناء الحمل أو الرضاعة الطبيعية. إذا كنتي حاملًا أو تقومين بالإرضاع، أو يُحتمل أن تصبحين حاملًا أو تخططين لإنجاب طفل، يجب عليكِ أخذ مشورة طبيبك أو الصيدلي قبل استعمال هذا الدواء.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد يتسبب ميتوبرولول تارترات في شعورك بالإرهاق والدوار. تأكد من عدم تأثرك قبل القيادة أو استعمال الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;خذ هذا الدواء دائمًا كما أخبرك طبيبك، وتحقق من طبيبك أو الصيدلي إن لم تكن متأكدًا.</p><p dir="RTL">&nbsp;يجب عدم تناول ميتوبرولول تارترات مع الطعام، ويجب أخذه على معدة فارغة.</p><p dir="RTL">يمكن تقسيم أقراص ميتوبرولول تارترات لجرعات متساوية.</p><p dir="RTL"><strong>الجرعة الموصي بها:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ارتفاع ضغط الدم:</strong> جرعة مبدئية مقدارها 100 مجم يوميًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ا<strong>لذبحة الصدرية:</strong> عادة ما تكون 50-100 مجم مرتان يوميًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اضطراب نبض القلب (اضطراب النظم):</strong><strong> </strong>100-200 مجم يوميًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>العلاج الحفاظي بعد الأزمات القلبية:</strong><strong> </strong>جرعة الحفاظ المعتادة هي 100 مجم مرتان يوميًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>منع الصداع النصفي:</strong> 50 - 100 مجم مرتان يوميًا.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا اخذت ميتولينا أكثر مما يجب</strong></p><p dir="RTL">إذا أخذت جرعة أكبر من الموصي بها بطريقة غير مقصودة، تواصل مع أقرب قسم للرعاية الطبية،</p><p dir="RTL">أو أخبر طبيبك أو الصيدلي على الفور. قد يحدث انخفاض كبير بضغط الدم وانخفاض بمعدل نبض القلب بناءً على درجة الجرعة المفرطة. وكنتيجة لإخفاق وظائف القلب، قد تحدث سكتة قلبية وضعف بعضلة القلب ونوبة قلبية. تتضمن الأعراض الأخرى مشاكل بالتنفس وانقباض بعضلات القصبة الهوائية وقيء واضطراب بالوعي ونوبات عامة في بعض الأحيان.</p><p>&nbsp;</p><p dir="RTL"><strong>إذا نسيت تناول ميتولينا</strong></p><p dir="RTL">إذا نسيت أخذ جرعة، فخذها بمجرد تذكرك. إلا إذا كان موعد الجرعة التالية قريبًا. وبعدها استمر وفقًا لجدول الجرعات المعتاد. لا تأخذ جرعة مزدوجة للتعويض عن الجرعة المنسية.</p><p>&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن أخذ ميتولينا</strong></p><p dir="RTL">لا تتوقف عن أخذ ميتوبرولول تارترات بشكل مفاجئ؛ فقد يؤدي ذلك إلى تفاقم فشل القلب وزيادة خطر حدوث النوبات القلبية. قم بتغيير الجرعة أو إيقاف العلاج فقط بعد استشارة طبيبك.</p><p>&nbsp;</p><p dir="RTL">اسأل طبيبك أو الصيدلي إن كانت لديك أي أسئلة إضافية حول استخدام هذا الدواء.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يتسبب هذا الدواء بآثار جانبية، بالرغم من عدم إصابة الجميع بها.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>توقف عن أخذ العلاج وتواصل مع الطبيب على الفور في حالة حدوث:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تفاعلات تحسسية</strong><strong> </strong>مثل الطفح الجلدي الذي تصاحبه حكة، أو تورم الوجه أو الشفتين أو اللسان أو الحلق، أو صعوبة التنفس أو البلع.</p><p dir="RTL">هذا آثر جانبي شديد الخطورة، ولكنه نادر في نفس الوقت.</p><p dir="RTL">وقد تحتاج حينئذ إلى علاج طبي عاجل.</p><p dir="RTL"><strong>أعلم طبيبك إذا لاحظت أي من الآثار الجانبية التالية، أو أي آثر آخر غير مُدرج:</strong></p><p dir="RTL"><strong>شائع جدًا </strong>(قد يُصيب أكثر من 1 لكل 10 أشخاص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإغماء عند الوقوف نتيجة انخفاض ضغط الدم، الإرهاق.</p><p dir="RTL"><strong>شائع</strong> (قد يُصيب 1 لكل 10 أشخاص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض نبض القلب،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة المحافظة على التوازن (قد يصاحبه إغماء بصورة نادرة)،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; برودة اليدين أو القدمين،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خفقان،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوخة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالإعياء،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إمساك،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام بالمعدة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة التنفس مع المجهود البدني الشاق.</p><p>&nbsp;</p><p dir="RTL"><strong>غير شائع</strong> (قد يُصيب 1 لكل 100 شخص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم الصدر،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الوزن،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اكتئاب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل التركيز</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القدرة على النوم (أرق)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نعاس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كوابيس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وخز بالجلد،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاقم مؤقت بأعراض فشل القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب التوصيل القلبي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انقباض تشنجي بالعضلات الملساء للشعب الهوائية (ينتج عنه صعوبة بالتنفس)،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قيء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة التعرق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتباس السوائل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشنجات عضلية</p><p>&nbsp;</p><p dir="RTL"><strong>نادر</strong> (قد يُصيب 1 لكل 1000 شخص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاقم مرض السكري،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عصبية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قلق،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات بصرية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف العينين أو تهيجها،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الملتحمة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف القدرة الجنسية، اضطرابات جنسية أخرى،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة بيروني (انحناء القضيب عند الانتصاب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب نبض القلب،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات التوصيل القلبي،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيلان الأنف،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات باختبارات وظائف الكبد.</p><p>&nbsp;</p><p dir="RTL"><strong>نادر جدًا</strong> (قد يُصيب 1 لكل 10000 شخص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات بخلايا الدم،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نسيان، اضطرابات الذاكرة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتباك،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هلوسة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات بالشخصية، مثل تغيرات المزاج،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رنين في الأذنين (طنين)،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل بالسمع،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات بالتذوق،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد (الالتهاب الكبدي)،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية تجاه الضوء،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاقم الصدفية أو حدوثها، تغيرات شبيهة بالصدفية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف العضلات،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام المفاصل،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موت الأنسجة لدي مرضى اضطرابات الدورة الدموية الشديدة.</p><p>&nbsp;</p><p dir="RTL"><strong><u>الإبلاغ عن الآثار الجانبية</u></strong></p><p dir="RTL">إذا أصبت بأي آثار جانبية، تواصل مع طبيبك أو الصيدلي. ويتضمن ذلك أي آثار جانبية محتملة غير مدرجة بهذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إحفظ هذا الدواء بعيدا عن نظر ومتناول الأطفال.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المكتوب على الشريط أو الكرتون بعد &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">&nbsp;يخزن في درجة حرارة أقل من&nbsp;30 درجة مئوية.</p><p dir="RTL">&nbsp;يُحفظ بعيدًا عن الضوء.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق الصرف الصحي أو النفايات المنزلية. وأسال الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه التدابير تساعد في حماية البيئة.</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;المادة الفعالة هي ميتوبرولول تارترات.</p><p dir="RTL">&nbsp;يحتوي كل قرص مغلف على 50 مجم أو 100 مجم من ميتوبرولول تارترات.</p><p dir="RTL">-&nbsp;&nbsp;المكونات الأخرى هي:</p><p dir="RTL"><em>&nbsp;جسم القرص:</em> سيليولوز دقيق التبلور، نشا ذرة، جليكولات صوديوم النشا، سيليكا غروية لا مائية، لوريل كبريتات الصوديوم، ستيرات ماغنسيوم.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p><p dir="RTL"><em>غلاف القرص:</em></p><p dir="RTL">50 مجم: هيبروميلوز، ثاني أكسيد التيتانيوم، بولي سوربات 80، تالك، أكسيد حديد أحمر.</p><p dir="RTL">100 مجم: هيبروميلوز، ثاني أكسيد التيتانيوم، ماكروجول، بولي سوربات 80، تالك، أزرق #2/صبغة إنديجو كارمين الألمونيومية الـترسيبية وفقًا للقانون الفيدرالي الأمريكي للغذاء والدواء ومستحضرات التجميل (FD&amp;C).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;قرص مُغلف.&nbsp;</p><p dir="RTL"><u>ميتولينا 50:&nbsp; </u></p><p dir="RTL">أقراص مستديرة مغلفة بلون الخوخ، محفور على أحد جانبيها &quot;C فوق 74&quot;، وخط عميق على الجانب الآخر.</p><p dir="RTL"><u>&nbsp;ميتولينا 100:&nbsp; </u></p><p dir="RTL">أقراص مستديرة مغلفة لونها أزرق فاتح، محفور على أحد جانبيها &quot;C فوق 75&quot;، وخط عميق على الجانب الآخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;أقراص ميتولينا المغلفة متاحة في عبوات تحتوي على شرائط شفافة مصنوعة من البولي فينيل كلوريد/بولي فينيليدين كلوريد ورقائق الألومنيوم.</p><p dir="RTL">تُورد أقراص ميتولينا 50 مجم و100 مجم المغلفة في عبوة تحتوي على 30 قرص (3 أشرطة يحتوي كل منها على 10 أقراص).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة المُصنعة :</strong></p><p dir="RTL">أوروبيندو فارما المحدودة، الوحدة&ndash; VII،</p><p dir="RTL">المنطقة الاقتصادية الخاصة، مؤسسة ولاية تيلانجانا للبنية التحتية الصناعية، قطعة رقم. SI، مسح رقم: 411/P، 425/P، 434/P، 435/P، 458/P،</p><p dir="RTL">الحديقة الصناعية الخضراء، قرية بوليبالي، منطقة جيدشيرلا،</p><p dir="RTL">حي ماهابوبناجار، ولاية تيلانجانا، الهند.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>حامل ترخيص التسويق:</strong></p><p dir="RTL">أوروبيندو فارما السعودية المحدودة،</p><p dir="RTL">جدة، المملكة العربية السعودية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            07/2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                METOLINA 50
(Metoprolol Tartrate Tablets BP 50 mg)
METOLINA 100
(Metoprolol Tartrate Tablets BP 100 mg)

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Metoprolol Tartrate Tablets BP 50 mg:
Each film-coated tablet contains Metoprolol Tartrate Ph.Eur 50 mg Metoprolol Tartrate Tablets BP 100 mg:
Each film-coated tablet contains Metoprolol Tartrate Ph.Eur. 100 mg For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Metoprolol Tartrate Tablets BP 50 mg:
Peach coloured, round shaped, film coated tablets, debossed with ‘C over 74’ on one side and deep score line on the other side.
Metoprolol Tartrate Tablets BP 100 mg:
Light blue coloured, round shaped, film coated tablets, debossed with ‘C over 75’ on one side and deep score line on the other side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Metoprolol tartrate is indicated in adults for:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertension.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Angina pectoris.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tachycardiac arrhythmia, particularly supraventricular tachycardia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prevention of cardiac death and re-infarction after the&nbsp;acute&nbsp;phase of&nbsp;myocardial infarction.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prophylaxis of migraine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>The dose must always be adjusted to the individual requirements of the patient but should not exceed 400 mg/day. The following are guidelines.</p><p><em>Adults:</em></p><p><u>Hypertension: </u>Initially 100 mg daily. This may be increased, if necessary, to 200 mg daily in single or divided doses. Combination therapy with another antihypertensive agent may also be considered to further reduce blood pressure.</p><p><u>Angina pectoris: </u>Usually 50-100 mg twice daily. The dose may be further increased or combined with nitrates.</p><p><u>Tachycardiac arrhythmias: </u>A daily dose of 100 - 200 mg is usually sufficient. If necessary the dose may be increased.</p><p><u>After acute intravenous treatment of myocardial infarction: </u>Orally, therapy should commence 15 minutes after the last intravenous injection with 50 mg every 6 hours for 48 hours.</p><p><u>Prophylaxis after myocardial infarction: </u>Maintenance dose is 100 mg twice daily.</p><p><u>Prophylaxis of migraine: </u>50-100 mg twice daily.</p><p><em>Patients with renal impairment:</em></p><p>The rate of elimination is insignificantly affected by renal function and therefore no dose adjustment is needed.</p><p><em>Patients with hepatic impairment:</em></p><p>Usually metoprolol can be given at the same dose to patients with cirrhosis of the liver as to patients with normal hepatic function. A dose reduction should only be considered when there are signs of severely impaired hepatic function (i.e. shunt operated patients) (see Section 5.2).</p><p><em>Elderly patients:</em></p><p>There are no adequate data from the use in patients above the age of 80. Take special precautions when increasing the dose. However, caution is advised in elderly patients as a fall in blood pressure or excessive bradycardia may have more pronounced effects.</p><p><em>Paediatric population:</em></p><p>There is limited data on the use of metoprolol in children and adolescents, therefore the use of Metoprolol tartrate is not recommended.</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>The tablets should be taken on an empty stomach (see section 5.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -	Hypersensitivity to metoprolol, other beta blockers or to any of the excipients listed in section 6.1.
-	Grade II or III atrioventricular block.
-	Patients with unstable or acute decompensated heart failure (pulmonary oedema, hypoperfusion or hypotension), in which case continuous or periodical intravenous inotropic β receptor agonist therapy is indicated.
-	Manifest and clinically significant sinus bradycardia (heart frequency < 50/min.).
-	Sick sinus syndrome.
-	Cardiogenic shock.
-	Severe peripheral arterial disease.
-	Hypotension (systolic < 90 mmHg).
-	Metabolic acidosis.
-	Severe bronchial asthma or chronic obstructive pulmonary disease.
-	Higher grade sinoatrial block

Metoprolol may not be administered to patients with suspected acute myocardial infarction and a heart rate of < 50 beats/min., PQ interval > 0.24 seconds or systolic blood pressure < 100 mmHg.
Concomitant intravenous administration of calcium blockers of the type verapamil or diltiazem or other antiarrhythmics (such as disopyramide) is contraindicated (exception: intensive care unit) (see section 4.5).
Untreated phaeochromocytoma.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Beta blockers must be administered with caution to asthmatics. If an asthmatic uses a beta-2 agonist (as tablets or by inhalation) when initiating metoprolol treatment, the dose of the beta-2 agonist must be controlled and increased if necessary.</p><p>Metoprolol&nbsp; &nbsp;may &nbsp;reduce&nbsp;&nbsp; the&nbsp;&nbsp; effect&nbsp;&nbsp; of&nbsp;&nbsp; diabetes&nbsp;&nbsp; treatment&nbsp;&nbsp; and&nbsp; &nbsp;mask &nbsp;the&nbsp; &nbsp;symptoms&nbsp; &nbsp;of hypoglycaemia.</p><p>AV conduction disorders may be aggravated in rare cases in connection with metoprolol treatment (possible atrioventricular block). Beta-blockers should be given only with caution to patients with first degree atrioventricular block (see section 4.3).</p><p>Metoprolol may exacerbate the symptoms of peripheral vascular disorders due to its antihypertensive effect.</p><p>When prescribing metoprolol to patients with a pheochromocytoma, an alpha blocker must be used before initiating treatment and during the metoprolol treatment.</p><p>In patients with Prinzmetal&#39;s angina &beta;1 selctive agents should be used with care because may increase the number and duration of angina attacks.</p><p>Metoprolol treatment may possibly mask the symptoms of thyreotoxicosis.Therefore, metoprolol should be administered with caution to patients having or suspected of developing thyreotoxicosis and both thyroid and cardiac functions should be monitored closely.</p><p>Before surgery, the anaesthesiologist must be informed that the patient takes beta blockers. It is not recommended to discontinue beta blocker treatment during a surgical procedure.</p><p>Beta blocker treatment must not be suddenly discontinued. If the treatment is to be discontinued, it must, where possible, be gradually reduced over a period of at least two weeks during which the dose is withdrawn gradually, the doses diminishing to 25 mg for the last 6 days before the treatment is discontinued. If the patient presents with any symptoms, the dose should be reduced at a lower rate. Sudden discontinuation of beta blockers may possibly exacerbate heart failure and increase the risk of myocardial infarction and sudden death.</p><p>Like other beta blockers, metoprolol may also increase both the sensitivity to allergens and the severity of anaphylactic reactions. Adrenalin treatment does not always give the desired therapeutic effect in individuals receiving beta blockers (see also section 4.5).</p><p>Beta blockers may trigger or exacerbate psoriasis.</p><p>Up to the present, there is insufficient data from the use of metoprolol in patients with heart failure and the following accompanying factors:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Unstable heart failure (NYHA IV).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Acute myocardial infarction or unstable angina pectoris in the preceding 28 days.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Impaired renal function.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Impaired hepatic function.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Patients above the age of 80.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Patients under the age of 40.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Haemodynamically significant valve diseases.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Hypertrophic obstructive cardiomyopathy.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; During or after cardiac surgery within the last four months before treatment with metoprolol. In the case of increasing bradycardia the dosage should be reduced, or treatment gradually discontinued.</p><p>Metoprolol tartrate may not be administered to patients with untreated congestive heart failure. The congestive heart failure needs to be brought under control first of all. If concomitant digoxin treatment is taking place, it must be borne in mind that both medicinal products slow AV conduction and that there is therefore a risk of AV dissociation. In addition, mild cardiovascular complications may occur, manifesting as dizziness, bradycardia, and a tendency to collapse.</p><p>Dry eyes either alone or, occasionally, with skin rashes has occurred. In most cases the symptoms cleared when metoprolol treatment was withdrawn. Patients should be observed carefully for potential ocular effects. If such effects occur, discontinuation of metoprolol should be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following combinations with metoprolol should be avoided:</p><p><u>Barbituric acid derivatives </u>Barbiturates (studied for pentobarbital) induce the metabolism of metoprolol through enzyme induction.</p><p><u>Propafenon </u>When propafenon was commenced in four patients, who were then treated with metoprolol, the plasma concentrations of metoprolol increased 2-5-fold and two patients suffered typical metoprolol side effects. The interaction was confirmed in a study involving eight healthy research subjects. The interaction is probably due to the fact that propafenon, like quinidine, inhibits the metabolism of metoprolol via cytochrome P450 2D6. The combination is probably difficult to manage due to the fact that propafenon also has beta-receptor blocking properties.</p><p><u>Calcium antagonists </u>In the case of the concomitant use of calcium antagonists of the verapamil or diltiazem types, an increase in negative inotropic and chronotropic effects can occur. Calcium antagonists of the verapamil type should not be administered intravenously to patients who are being treated with beta blockers, due to the risk of hypotension, AV conduction disturbances, and left ventricular insufficiency (see section 4.3). In patients with impaired cardiac function, the combination is contraindicated. As with other beta-blockers, concomitant therapy with dihydropyridines (such as nifedipine and amlodipine), may increase the risk of hypotension, and cardiac failure may occur in patients with latent cardiac insufficiency.</p><p>&nbsp;</p><p>The following combinations with metoprolol may require dose adjustment:</p><p><u>Amiodarone </u>One case history indicates that patients treated with amiodarone can develop severe sinus bradycardia during concomitant treatment with metoprolol. Amiodarone has an extremely long half-life (approximately 50 days), which means that interactions can occur a long time after discontinuation of the preparation.</p><p><u>Class I-antiarrhythmics </u>Class I-antiarrhythmics and beta-receptor blockers have additive negative inotropic effects, which can result in serious haemodynamic adverse reactions in patients with impaired left-ventricular function. The combination should be avoided in &ldquo;sick sinus syndrome&rdquo; and pathological AV-conduction. The interaction is best documented for disopyramide.</p><p><u>Non-steroidal anti-inflammatory drugs/antirheumatic agents (NSAID) </u>NSAID-type antiphlogistics counteract the antihypertensive effect of beta-receptor blocking agents. Studies have primarily been performed on indomethacin. This interaction is not believed to occur with sulindac. It has not been possible to demonstrate such an interaction in a study relating to diclofenac.</p><p><u>CYP2D6 inhibitors </u>Metoprolol is a CYP2D6-substrate. Drugs which inhibit this enzyme may increase the plasma concentration of metoprolol. Examples of clinically significant inhibitors of CYP2D6 are antidepressants such as fluoxetine, paroxetine or bupropion, antipsychotics such as thioridazine, antiarrhythmics such as propafenone, antiretrovirals such as ritonavir, antihistamines such as diphenhydramine, antimalarials such as hydroxychloroquine or quinidine, antifungals such as terbinafine and medications for stomach ulcers such as cimetidine. On commencement of treatment with these medicinal products in patients being treated with metoprolol the dose of metoprolol may need to be reduced.</p><p><u>Diphenhydramine </u>Diphenhydramine reduces (2.5 times) clearance of metoprolol to alpha- hydroxymetoprolol in fast hydroxylaters via CYP 2 D6, at the same time as the effects of metoprolol are increased.</p><p><u>Digitalis glycosides </u>Digitalis glycosides in connection with beta-receptor blockers, can increase the atrioventricular conduction time and induce bradycardia.</p><p><u>Epinephrine </u>A dozen reports exist in respect of severe hypertension and bradycardia in patients treated with nonselective beta-receptor blockers (including pindolol and propanalol), who were administered epinephrine (adrenaline). These clinical observations have been confirmed in studies on healthy research subjects. It has also been suggested that epinephrine, administered as</p><p>local anaesthesia, may give rise to these reactions on intravasal administration. The risk should be considerably less with cardioselective beta-receptor blockers.</p><p><u>Phenylpropanolamine </u>Phenylpropanolamine (norephedrine) in single doses of 50 mg may increase the diastolic blood pressure to pathological levels in healthy research subjects. In general, propanolol counteracts the rise in blood pressure triggered by phenylpropanolamine. Beta-receptor blockers may, however, trigger paradoxical hypertensive reactions in &nbsp;patients taking high doses of phenylpropanolamine. Hypertensive crises during treatment solely with phenylpropanolamine have been described in a couple of cases.</p><p><u>Quinidine </u>Quinidine inhibits the metabolism of metoprolol in so-called &ldquo;fast hydroxylaters&rdquo; (just over 90% in Sweden), with significantly increased plasma values and resultant increase in beta blockade. Similar reaction might be expected to occur with other beta-blockers which are metabolized by the same enzyme (cytochrome P450 2 D6).</p><p><u>Sympathetic ganglion blockers, or other beta blockers </u>Patients who are concomitantly receiving sympathetic ganglion blockers, or other beta blockers (including in the form of eye drops) must continue being monitored.</p><p><u>MAO inhibitors </u>MAO inhibitors should be used with caution as concomitant administration with beta-blockers may result in bradycardia and an enhanced hypotensive effect. Monitoring of blood pressure and heart rate are recommended during initial use.</p><p><u>Centrally-acting antihypertensives (clonidine, guanfacin, moxonidine, methyldopa, rilmenidine)</u> Abrupt withdrawal, particularly if prior to beta-blocker discontinuation, may increase risk of &ldquo;rebound hypertension&rdquo;.</p><p>The concomitant use of clonidine with a non-selective beta blocker, and possibly also with a selective beta blocker, increases the risk of rebound hypertension. If clonidine is administered concomitantly, the administration of the clonidine medication needs to be continued for some time after beta-blocker therapy is discontinued.</p><p><u>Paroxetine </u>may increase plasma levels of metoprolol resulting in increased beta-blocking effects. <u>Ergotamine </u>As beta-blockers may affect the peripheral circulation, care should be exercised when drugs with similar activity, e.g. ergotamine are given concurrently.</p><p><u>Nitrates </u>Nitrates may enhance the hypotensive effect of metoprolol.</p><p><u>Parasympathomimetics </u>Concurrent use of parasympathomimetics may result prolonged bradycardia.</p><p><u>Sympathomimetics </u>Metoprolol will antagonize the &beta;1 effect of sympathomimetic agent but should have little influence on the bronchodilator effects of &beta;2 agonists at normal therapeutic dose.</p><p><u>General anaesthetics </u>An increase in the cardio-depressive effect due to the concomitant administration of inhalational anaesthetics is possible; however, since beta blockade can prevent excessive fluctuations in blood pressure whilst the patient is intubated and is rapidly antagonised with beta sympathomimetics, concomitant use is not contraindicated (see section 4.4).</p><p><u>Insulin and oral antidiabetic agents </u>The blood glucose-reducing effect of insulin and oral blood glucose-reducing drugs can be intensified by beta blockers, in particular non-selective beta blockers. In this case, the dosage of the oral blood glucose-reducing drug must be adjusted.</p><p><u>Alpha blockers such as prazosine, tamsulosin, terazosine, doxazosine </u>Increased risk of hypotension, especially severe orthostatic hypotension.</p><p><u>Floctafenine: </u>Beta blockers may impede the compensatory cardiovascular reactions associated with hypotension or shock that may be induced by floctafenine.</p><p><u>Skeletal muscle relaxant </u>Curare muscle relaxant with metoprolol enhanced neuromuscular blockade. Blood pressure should be monitored and dosage adjustment of the antihypertensive be made if necessary.</p><p><u>Lidocaine </u>Metoprolol can reduce the clearance of lidocaine.</p><p><u>Hepatic enzyme inducers </u>Enzyme inducing agents (e.g. rifampicin) may reduce plasma concentrations of metoprolol.</p><p><u>Mefloquine </u>Increased risk of bradycardia.</p><p><u>Antacid </u>An increase in the plasma concentrations of metoprolol has been observed when the drug was coadministered with an antacid.</p><p><u>Alcohol </u>During concomitant ingestion of alcohol and metoprolol the concentration of blood alcohol may reach higher levels and may decrease more slowly.</p><p>The effects of metoprolol and other antihypertensive drugs on blood pressure are usually additive. Care should be taken when combining with other antihypertensive drugs or drugs that might reduce blood pressure, such as tricyclic antidepressants, barbiturates and phenothiazines. However, combinations of antihypertensive drugs may often be used with benefits to improve control of hypertension.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pregnancy:</em></p><p>Since there are no well-controlled studies of the use of metoprolol in pregnant women, metoprolol may only be used during pregnancy if the benefits to the mother outweigh the risk to the embryo/foetus.</p><p>Beta blockers reduce placental perfusion and may cause foetal death and premature birth. Intrauterine growth retardation has been observed after long term treatment of pregnant women with mild to moderate hypertension. Beta blockers have been reported to cause prolonged delivery and bradycardia in the foetus and the newborn child. There are also reports of hypoglycaemia, hypotension, increased bilirubinaemia and inhibited response to anoxia in newborn children. Therefore the lowest possible dose should be used, and treatment should be discontinued 48-72 hours before the calculated birth date. If this is not possible, the newborn child should be monitored for 48-72 hours post partum for signs and symptoms of beta blocking (e.g. cardiac and pulmonary complications).</p><p>Beta blockers have not shown potential teratogenic activity in animals, but reduced blood flow in the umbilical cord, growth retardation, reduced ossification and increased numbers of foetal and post-natal deaths.</p><p><em>Breast-feeding:</em></p><p>The concentration of metoprolol in breast milk is approximately three times higher than the one in the mother&#39;s plasma. Even though the risk of adverse effects in the breastfeeding baby would appear to be low after administration of therapeutic doses of the medicinal product (except in individuals with poor metabolic capacity), breastfeeding babies should be monitored for signs of beta blocking.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with all beta-blockers, metoprolol may affect patients&#39; ability to drive and operate machinery. It should be taken into account that occasionally dizziness or fatigue may occur. Patients should be warned accordingly. These effects may possibly be enhanced in case of concomitant ingestion of alcohol or after changing to another medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Metoprolol is well tolerated, and the undesirable effects are generally mild and reversible. The most commonly reported adverse reactions during treatment is fatigue. Gangrene (in patients with severe peripheral circulatory disorder), thrombocytopenia and agranulocytosis may occur</p><p>&nbsp;</p><p>very rarely (less than 1 case per 10,000 patients).The following undesirable effects have been reported during the course of clinical studies or have been reported after routine use. In many cases, a link with the use of metoprolol (tartrate) has not been firmly established.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td rowspan="4" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>common</p></td><td style="vertical-align:top"><p>(&ge; &nbsp;1/100 &nbsp;to</p></td><td style="vertical-align:top"><p>(&ge; 1/1,000 to &lt;</p></td><td style="vertical-align:top"><p>(&ge; 1/10,000 to</p></td><td rowspan="3" style="vertical-align:top"><p>(&lt; 1/10,000)</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>(&ge; 1/10)</p></td><td style="vertical-align:top"><p>&lt;&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>1/100)</p></td><td rowspan="2" style="vertical-align:top"><p>&lt; 1/1,000</p></td></tr><tr><td style="vertical-align:top"><p>1/10)</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Thrombocytopenia, leukopenia</p></td></tr><tr><td style="vertical-align:top"><p>Endocrine disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Deterioration of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; latent diabetes mellitus.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Weight gain.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Depression, concentration problems, drowsiness or insomnia, nightmares.</p></td><td style="vertical-align:top"><p>Nervousness, anxiety.</p></td><td style="vertical-align:top"><p>Forgetfulness or memory impairment, confusion, hallucinations, personality changes (e.g. mood changes).</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dizziness, headache.</p></td><td style="vertical-align:top"><p>Paresthesia.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Visual disturbances, dry&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or</p><p>irritated eyes, conjunctivitis.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Ear&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and</p><p>labyrinth disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Tinnitus, hearing problems.</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Bradycardia, balance disturbances (very &nbsp;rarely with associated syncope), palpitations.</p></td><td style="vertical-align:top"><p>Temporary exacerbation &nbsp;of symptoms&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of heart&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; failure, first degree atrioventricular block,</p><p>precordial pain.</p></td><td style="vertical-align:top"><p>Functional heart symptoms, heart arrhythmia, conductivity disturbances.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Pronounced blood pressure drop and orthostatic hypotension, very</p><p>rarely with syncope.</p></td><td style="vertical-align:top"><p>Cold&nbsp;&nbsp;&nbsp;&nbsp; hands and feet.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Necrosis in patients with severe peripheral vascular disorders prior to treatment, exacerbation of claudicatio intermittens or Raynaud&#39;s syndrome.</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Functional dyspnea.</p></td><td style="vertical-align:top"><p>Bronchospasms.</p></td><td style="vertical-align:top"><p>Rhinitis.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Nausea, abdominal pain, diarrhoea, constipation.</p></td><td style="vertical-align:top"><p>Vomiting.</p></td><td style="vertical-align:top"><p>Dryness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of mouth.</p></td><td style="vertical-align:top"><p>Taste disturbances.</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Abnormal LFT</p><p>values.</p></td><td style="vertical-align:top"><p>Hepatitis.</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rash (psoriasis like urticaria and dystrophic cutaneous lesions), increased perspiration.</p></td><td style="vertical-align:top"><p>Hair loss.</p></td><td style="vertical-align:top"><p>Light hypersensitivity reactions, exacerbation of psoriasis, new psoriasis manifestation, psoriasis-like dermatological changes.</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Muscle spasms.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Arthralgia, muscle weakness.</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and breast</p><p>disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Impotence and</p><p>other sexual dysfunctions, induratio penis</p><p>plastica (Peyronie&#39;s syndrome).</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and</p></td><td style="vertical-align:top"><p>Fatigue.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Oedema.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>administration site conditions</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Saudi Arabia:</em></strong></p><p><strong><em>&nbsp;</em></strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>-&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Center (NPC)</p><p>&nbsp; &middot;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&nbsp; &middot;&nbsp; &nbsp; &nbsp;SFDA Call Center: 19999</p><p>&nbsp; &middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Toll free phone: 8002490000</p><p>&nbsp; &middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E-mail: npc.drug@sfda.gov.sa</p><p>&nbsp; &middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Other</em></strong><strong><em> GCC States:</em></strong></p><p><strong><em>&nbsp;</em></strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>- &nbsp;Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Toxicity:</em></p><p>7.5 g to an adult resulted in a lethal intoxication. 100 mg to a 5-year-old did not result in any symptoms after gastric lavage. 450 mg to a 12-year-old and 1.4 g to an adult resulted in moderate intoxication. 2.5 g to an adult resulted in a serious intoxication and 7.5 g to an adult resulted in a very serious intoxication.</p><p><em>Symptoms:</em></p><p>An overdose of metoprolol may cause severe hypotension, sinus bradycardia, atrioventricular block, heart failure, cardiogenic shock, cardiac arrest, asystole, QT-prolongation (isolated cases), poor peripheral perfusion, bronchospasms, loss of consciousness (even coma), nausea, vomiting or cyanosis. Respiratory depression, apnea, fatigue, fine tremor, seizures, sweating, paraesthesias, possible oesophageal spasm, hypoglycaemia (especially in children) or hyperglycaemia, hyperkalaemia, renal effects, transient symptoms of myasthenia.</p><p>In certain cases, especially among children and adolescents, CNS-symptoms and respiratory depression may predominate.</p><p>The symptoms may be exacerbated by concomitant ingestion of alcohol, antihypertensive agents, chinidine or barbiturates.</p><p>The first signs of an overdose present within 20 minutes to 2 hours after taking the medicinal product. The effects of massive overdose may persist for several days, despite declining plasma concentrations.</p><p><em>Management:</em></p><p>Patients should be admitted to hospital and, generally, should be managed in an intensive care setting, with continuous monitoring of cardiac function, blood gases, and blood biochemistry. Emergency supportive measures such as artificial ventilation or cardiac pacing should be instituted if appropriate. Even apparently well patients who have taken a small overdose should be closely observed for signs of poisoning for at least 4 hours.</p><p>Active charcoal, gastric lavage if necessary. NOTE! Atropine (0.25-0.5 mg i.v. to adults, 10-20 micrograms/kg to children) should be <em>administered prior </em>to gastric lavage (due to the risk of vagal stimulation). Intubation and assisted ventilation should occur based on a very wide indication. Adequate volume substitution. Glucose infusion. ECG monitoring.</p><p>Atropine sulphate may be administered (0.5 - 2.0 mg intravenously) for blocking the vagus nerve. This can be repeated.</p><p>In case of severe hypotension, bradycardia or in risk of heart failure, the patient could be given a beta-1 agonist (e.g. prenalterol or isoprenaline) intravenously at intervals of 2-5 minutes or as continuous infusion until achieving the desired effect. If a selective beta-1 agonist is unavailable, dopamine may be used.</p><p>If the desired effect is not achieved, another sympathomimetic agent may be used, e.g. dobutamine or noradrenaline.</p><p>The patient may also be given 1-10 mg glucagon. It may be necessary to use a pacemaker. A beta-2 agonist may be administered intravenously to prevent bronchospasms in the patient, the patients should be monitored for evidence of cardiac arrhythmias during and after administration of the bronchodilator.</p><p>Note! The doses required for managing overdoses are much higher than the therapeutic doses usually applied as the beta blocker has blocked the beta receptors.</p><p>Note! In case of cardiac arrest after overdosage with a beta-blocker, cardiopulmonary resuscitation during several hours may be required.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>1.1&nbsp; </strong>Pharmacotherapeutic group: Beta blockers, selective. ATC Code: C 07 AB 02.</p><p><em>Mechanism of Action</em></p><p>Metoprolol is a beta-1 selective beta blocker.</p><p>It has a relatively greater blocking effect on beta1-receptors&nbsp;(i.e.&nbsp;those&nbsp;mediating&nbsp;adrenergic&nbsp;stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors which are chiefly involved in broncho and vasodilation.</p><p>Metoprolol only exhibits insignificant membrane stabilising effect and has no agonist effect. Metoprolol reduces or blocks the stimulating effect of catecholamines (particularly released in case of physical or mental stress) on the heart. Metoprolol reduces tachycardia, decreases the cardiac output and the contractility, and lowers the blood pressure.</p><p>If required, metoprolol may be administered concomitantly with a beta-2 agonist to patients with symptoms of obstructive pulmonary disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Absorption and distribution:</em></p><p>Metoprolol is completely absorbed after an oral dose, peak plasma concentrations occurring</p><p>1.5 &ndash; 2 hours after dosing. Due to a pronounced first passage metabolism for metoprolol, the bioavailability of a single oral dose is approx. 50 %. Concomitant intake of food increases bioavailability to approximately 70% Only a small fraction of metoprolol (approx. 5-10 %) binds to plasma proteins. Metoprolol crosses the placenta, and is found in breast milk. <em>Biotransformation and elimination:</em></p><p>Metoprolol is metabolised by hepatic oxidation. The three known main metabolites have been shown not to have a clinically significant beta blocking effect.</p><p>Metoprolol is metabolised primarily, but not solely, by the hepatic enzyme cytochrome (CYP) 2D6. Due to the polymorphy of the CYP 2D6 gene, the turnover rates vary with the individual. Individuals with poor metabolic capacity (approx. 7-8%) exhibit higher plasma concentrations and slower elimination than individuals with good metabolic capacity. The plasma concentrations are stable and repeatable in the individuals, however.</p><p>More than 95 % of an oral dose is excreted in urine. Approximately 5 % of the dose is excreted in unchanged form; in single cases up to an entire 30 %. The elimination half-life of metoprolol in plasma is 3.5 hours on average (interval 1-9 hours). Total clearance is approx. 1 L/min.</p><p>The pharmacokinetics of metoprolol in the elderly is not significantly different from that in younger populations. The systemic bioavailability and elimination of metoprolol is normal in renal failure patients. The elimination of metabolites is slower than normal, however. Significant accumulation of metabolites has been observed in patients with a glomerular filtration rate of less than 5 mL/min. The metabolite accumulation does not potentiate the beta blocking action of metoprolol.</p><p>Patients with hepatic cirrhosis may experience an increase in the bioavailability of metoprolol and a decline in total clearance. However, the exposure increase only has clinical relevance in patients with severely impaired hepatic function or portocaval shunt. In patients with portocaval shunt, the total clearance is approx. 0.3 L/min, and the AUC values are approx. six times larger than in healthy individuals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no other relevant preclinical data than those already mentioned in other sections of this summary of product characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Metoprolol Tartrate Tablets BP 50 mg</em>: Microcrystalline cellulose, Maize starch, Sodium starch glycolate, Silica colloidal anhydrous, Sodium lauryl sulfate, Talc, Magnesium stearate, Opadry pink and Purified water.</p><p><em>Metoprolol Tartrate Tablets BP 100 mg</em>: Microcrystalline cellulose, Maize starch, Sodium starch glycolate, Silica colloidal anhydrous, Sodium lauryl sulfate, Talc, Magnesium stearate, Opadry blue and Purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in the original package in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clear PVC/PVdC &ndash; Aluminium foil blister pack: 30&#39;s pack (10&#39;s Blister x 3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any &nbsp;unused &nbsp;product &nbsp;or &nbsp;waste &nbsp;material &nbsp;should &nbsp;be &nbsp;disposed &nbsp;of &nbsp;in &nbsp;accordance &nbsp;with &nbsp;local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aurobindo Pharma Saudi Arabia Limited, Jeddah, Saudi Arabia.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>